Your Ultimate Investment Research Platform
MarketBeat All-Access is the all-in-one stock research solution that saves you time and helps you make more money. You get our top stock picks, best-in-class research tools, proprietary research reports and much more.
Claim Your Free 30 Day Subscription
Michael Castagna net worth and biography

Michael Castagna Biography and Net Worth

CEO of MannKind

Michael Castagna is the CEO of MannKind Corporation, a role he has held since March 2016. He also serves on the company’s board of directors.

MannKind is a biopharmaceutical company focused on discovery, development, and commercialization of therapeutics for diseases like diabetes and pulmonary arterial hypertension. In his role as CEO, Dr. Castagna is focused on strategic development of the company’s people and products.

Dr. Castagna had a 14-year career as a pharmacist with CVS before fully transitioning to the business side of the industry. Before joining MannKind, he held various executive positions at Merck Serono, Sandoz, Pharmasett, Bristol-Myers Squibb, and most recently, Amgen, where he served as vice president, global commercial lead for a portfolio of nine biosimilar drugs.

While at BMS, he helped lead the relaunch of Orencia IV and the launch of Orencia SC, both drugs targeting rheumatoid arthritis. At Sandoz, he helped relaunch its lead product, a human growth hormone called Omnitrope. 

In his free time, Castagna serves on the board of directors of Pet Partners, a nonprofit organization with a mission of improving people’s health through positive interactions with therapy animals. 

He earned his B.S. in pharmacy from the University of the Sciences in Philadelphia, his M.B.A. in entrepreneurial studies from the University of Pennsylvania’s Wharton School of Business, and his doctor of pharmacy degree from the Massachusetts College of Pharmacy and Health Sciences.

What is Michael Castagna's net worth?

The estimated net worth of Michael Castagna is at least $10.87 million as of June 1st, 2023. Dr. Castagna owns 2,516,735 shares of MannKind stock worth more than $10,872,295 as of June 7th. This net worth evaluation does not reflect any other investments that Dr. Castagna may own. Learn More about Michael Castagna's net worth.

What is Michael Castagna's salary?

As the CEO of MannKind Co., Dr. Castagna earned a total compensation package of $4,030,833.00 in 2021. Dr. Castagna earned a salary of $598,462.00, stock awards of $2,911,592.00, non-equity compensation of $481,762.00, and other compensation of $39,017.00. Learn More on Michael Castagna's salary.

How do I contact Michael Castagna?

The corporate mailing address for Dr. Castagna and other MannKind executives is 30930 RUSSELL RANCH ROAD SUITE 300, WESTLAKE VILLAGE CA, 91362. MannKind can also be reached via phone at (818) 661-5000 and via email at [email protected]. Learn More on Michael Castagna's contact information.

Has Michael Castagna been buying or selling shares of MannKind?

During the past quarter, Michael Castagna has sold $1,167,600.00 in shares of MannKind stock. Most recently, Michael Castagna sold 10,000 shares of the business's stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $4.53, for a transaction totalling $45,300.00. Following the completion of the sale, the chief executive officer now directly owns 2,516,735 shares of the company's stock, valued at $11,400,809.55. Learn More on Michael Castagna's trading history.

Who are MannKind's active insiders?

MannKind's insider roster includes Steven Binder (CFO), Michael Castagna (CEO), Alejandro Galindo (Insider), David Thomson (EVP), and Stuart Tross (Insider). Learn More on MannKind's active insiders.

Are insiders buying or selling shares of MannKind?

In the last twelve months, MannKind insiders bought shares 5 times. They purchased a total of 18,100 shares worth more than $53,033.00. In the last twelve months, insiders at the biopharmaceutical company sold shares 10 times. They sold a total of 420,001 shares worth more than $1,934,326.13. The most recent insider tranaction occured on June, 1st when CEO Michael Castagna sold 10,000 shares worth more than $45,300.00. Insiders at MannKind own 4.0% of the company. Learn More about insider trades at MannKind.

Information on this page was last updated on 6/1/2023.

Michael Castagna Insider Trading History at MannKind

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/1/2023Sell10,000$4.53$45,300.002,516,735View SEC Filing Icon  
5/26/2023Sell75,000$4.50$337,500.002,526,735View SEC Filing Icon  
5/24/2023Sell150,000$4.69$703,500.002,331,735View SEC Filing Icon  
5/5/2023Sell10,000$4.00$40,000.002,020,128View SEC Filing Icon  
4/3/2023Sell10,000$4.13$41,300.002,030,128View SEC Filing Icon  
3/1/2023Sell10,000$5.27$52,700.002,040,128View SEC Filing Icon  
7/31/2022Buy3,147$2.93$9,220.712,084,486View SEC Filing Icon  
7/30/2021Buy5,000$2.99$14,950.00View SEC Filing Icon  
3/5/2021Buy3,000$3.38$10,140.00View SEC Filing Icon  
6/15/2020Buy30,000$1.49$44,700.00198,560View SEC Filing Icon  
6/12/2020Buy68$1.41$95.88198,560View SEC Filing Icon  
1/31/2019Buy5,000$1.07$5,350.0098,157View SEC Filing Icon  
8/2/2018Buy5,000$1.31$6,550.0068,157View SEC Filing Icon  
12/20/2017Buy8,000$2.29$18,320.0035,532View SEC Filing Icon  
8/26/2016Buy17,500$0.78$13,650.00212,500View SEC Filing Icon  
8/24/2016Buy15,000$0.87$13,050.00195,000View SEC Filing Icon  
8/23/2016Buy25,000$0.94$23,500.00180,000View SEC Filing Icon  
8/12/2016Buy25,000$1.00$25,000.0075,000View SEC Filing Icon  
5/17/2016Buy50,000$0.93$46,500.0050,000View SEC Filing Icon  
See Full Table

Michael Castagna Buying and Selling Activity at MannKind

This chart shows Michael Castagna's buying and selling at MannKind by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

MannKind Company Overview

MannKind logo
MannKind Corp. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic products and devices for those with endocrine and orphan lung diseases. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Read More

Today's Range

Now: $4.17
Low: $4.11
High: $4.44

50 Day Range

MA: $4.20
Low: $3.72
High: $4.79

2 Week Range

Now: $4.17
Low: $2.91
High: $5.73


1,670,465 shs

Average Volume

3,187,503 shs

Market Capitalization

$1.10 billion

P/E Ratio


Dividend Yield



Yours Free! Top FIVE Dividend Stocks Right Now
This Ultimate Dividend Package contains an "A"-rated, ultra-safe dividend stock with a huge 8% yield, and one income expert's No. 1 dividend stock for a LIFETIME of income. 

Click here to get your FREE Ultimate Dividend Package.